摘要
目的:分析4种抗菌药物治疗婴幼儿支气管肺炎的成本—效果。方法:104例支气管患儿,随机分为A、B、C、D4组,分别给予阿莫西林克拉维酸钾、头孢西丁、头孢米诺、头孢哌酮舒巴坦4种抗生素,计算比较4组总有效率(E)、总成本(C)、成本—效果(C/E),以A、B、C、D组分别作为参照标准计算增加成本—效果(ΔC/ΔE)。结果:4组有效率分别为76.9%、80.8%、92.3%、96.2%,总成本分别为353.8、284.、325.6、192.7元,成本—效果分别为4.6、3.5、3.5、2.0。结论:使用头孢哌酮舒巴坦治疗婴幼儿支气管肺炎其经济性与合理性优于阿莫西林克拉维酸钾、头孢西丁、头孢米诺,有临床推广的意义。
Objective：To analyze the effects of 4 kinds of antibiotics in the treatment of infant bronchial pneumonia cost. Methods：104 cases with bronchiolitis, Were randomly divided into A, B, C, D4 group, were treated with amoxicillin and clavulanate potassium, cefoxitin, cefminox, cefoperazone sulbactam four kinds of antibiotics, calculated the total efficiency of 4 groups（E）, total cost（C）, cost -effectiveness （C/E）, A, B, C,D group respectively, increase cost effectiveness as the reference standard （ΔC/ΔE）. Results：The 4 groups respectively 76.9%, 80.8%, 92.3%, 96.2%,The total costs were 353.8, 284, 325.6, 192.7 yuan,Cost effectiveness respectively 4.6, 3.5, 3.5, 2.0. Conclusion： The use of cefoperazone sulbactam in the treatment of infant bronchial pneumonia and its economy and rationality is superior to amoxicillin and clavulanate potassium, cefoxitin, cefminox , have clinical significance.
出处
《甘肃医药》
2015年第10期734-737,共4页
Gansu Medical Journal
关键词
抗生素
支气管肺炎
成本效果
antibiotics
Bronchial pneumonia
cost-effect
